DD242749A5 - Verbesserte entzuendungshemmende zusammensetzungen und verfahren - Google Patents
Verbesserte entzuendungshemmende zusammensetzungen und verfahren Download PDFInfo
- Publication number
- DD242749A5 DD242749A5 DD86286631A DD28663186A DD242749A5 DD 242749 A5 DD242749 A5 DD 242749A5 DD 86286631 A DD86286631 A DD 86286631A DD 28663186 A DD28663186 A DD 28663186A DD 242749 A5 DD242749 A5 DD 242749A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- piroxicam
- inositol
- gastric
- inflammatory
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/696,686 US4559326A (en) | 1985-01-31 | 1985-01-31 | Antiinflammatory compositions and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
DD242749A5 true DD242749A5 (de) | 1987-02-11 |
Family
ID=24798136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD86286631A DD242749A5 (de) | 1985-01-31 | 1986-01-30 | Verbesserte entzuendungshemmende zusammensetzungen und verfahren |
Country Status (20)
Country | Link |
---|---|
US (1) | US4559326A (zh) |
EP (1) | EP0190851B1 (zh) |
JP (1) | JPS61176524A (zh) |
CN (1) | CN1010550B (zh) |
AT (1) | ATE49120T1 (zh) |
AU (1) | AU558587B2 (zh) |
CA (1) | CA1255593A (zh) |
DD (1) | DD242749A5 (zh) |
DE (1) | DE3667913D1 (zh) |
DK (1) | DK165966C (zh) |
EG (1) | EG17890A (zh) |
ES (1) | ES8800048A1 (zh) |
GR (1) | GR860248B (zh) |
HU (1) | HU194736B (zh) |
IE (1) | IE58368B1 (zh) |
IL (1) | IL77742A0 (zh) |
NZ (1) | NZ214985A (zh) |
PH (1) | PH22206A (zh) |
PT (1) | PT81933B (zh) |
ZA (1) | ZA86689B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8426152D0 (en) * | 1984-10-16 | 1984-11-21 | Reckitt & Colmann Prod Ltd | Medicinal compositions |
KR890001236B1 (ko) * | 1985-10-02 | 1989-04-28 | 화이자 인코포레이티드 | 소염제 조성물의 제조방법 |
GB8608818D0 (en) * | 1986-04-11 | 1986-05-14 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
JPH07116026B2 (ja) * | 1987-07-07 | 1995-12-13 | 株式会社資生堂 | ジクロフェナックナトリウム含有乳化外用剤 |
JP2964195B2 (ja) * | 1992-04-28 | 1999-10-18 | エスエス製薬株式会社 | ピロキシカム錠及びその製造法 |
US5807568A (en) * | 1994-12-27 | 1998-09-15 | Mcneil-Ppc, Inc. | Enhanced delivery of topical compositions containing flurbiprofen |
US6492334B1 (en) * | 1999-12-30 | 2002-12-10 | Robert James Generale | Tri-compound analgesic for treating inflammation and pain |
KR100406576B1 (ko) * | 2001-06-23 | 2003-11-20 | 최후균 | 경피투여용 패취제 |
CN108309960A (zh) * | 2018-04-24 | 2018-07-24 | 温州医科大学附属第医院 | 肌醇在制备抗炎药物中的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2221128A2 (en) * | 1973-03-13 | 1974-10-11 | Fabre Sa Pierre | Aspirin - polyol compsns. - contg. inositol, ribitol or glucuronic acid - free from ulcerogenic activity |
US4434164A (en) * | 1981-06-01 | 1984-02-28 | Pfizer Inc. | Crystalline benzothiazine dioxide salts |
-
1985
- 1985-01-31 US US06/696,686 patent/US4559326A/en not_active Expired - Fee Related
-
1986
- 1986-01-24 DE DE8686300494T patent/DE3667913D1/de not_active Expired - Fee Related
- 1986-01-24 AT AT86300494T patent/ATE49120T1/de not_active IP Right Cessation
- 1986-01-24 EP EP86300494A patent/EP0190851B1/en not_active Expired - Lifetime
- 1986-01-28 GR GR860248A patent/GR860248B/el unknown
- 1986-01-29 ES ES551390A patent/ES8800048A1/es not_active Expired
- 1986-01-29 CA CA000500574A patent/CA1255593A/en not_active Expired
- 1986-01-29 PT PT81933A patent/PT81933B/pt not_active IP Right Cessation
- 1986-01-30 DD DD86286631A patent/DD242749A5/de unknown
- 1986-01-30 DK DK045486A patent/DK165966C/da not_active IP Right Cessation
- 1986-01-30 HU HU86436A patent/HU194736B/hu not_active IP Right Cessation
- 1986-01-30 AU AU52842/86A patent/AU558587B2/en not_active Ceased
- 1986-01-30 IL IL77742A patent/IL77742A0/xx not_active IP Right Cessation
- 1986-01-30 IE IE26986A patent/IE58368B1/en not_active IP Right Cessation
- 1986-01-30 PH PH33353A patent/PH22206A/en unknown
- 1986-01-30 EG EG46/86A patent/EG17890A/xx active
- 1986-01-30 ZA ZA86689A patent/ZA86689B/xx unknown
- 1986-01-30 NZ NZ214985A patent/NZ214985A/xx unknown
- 1986-01-30 CN CN86100749A patent/CN1010550B/zh not_active Expired
- 1986-01-31 JP JP61020033A patent/JPS61176524A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
EP0190851B1 (en) | 1990-01-03 |
PT81933A (en) | 1986-02-01 |
AU558587B2 (en) | 1987-02-05 |
DK45486D0 (da) | 1986-01-30 |
IE58368B1 (en) | 1993-09-08 |
CN86100749A (zh) | 1986-10-15 |
PT81933B (pt) | 1988-05-27 |
DK165966C (da) | 1993-08-16 |
HUT39605A (en) | 1986-10-29 |
ES551390A0 (es) | 1987-11-01 |
CA1255593A (en) | 1989-06-13 |
CN1010550B (zh) | 1990-11-28 |
JPS61176524A (ja) | 1986-08-08 |
NZ214985A (en) | 1988-09-29 |
PH22206A (en) | 1988-06-28 |
ATE49120T1 (de) | 1990-01-15 |
DK165966B (da) | 1993-02-22 |
GR860248B (en) | 1986-05-29 |
EP0190851A1 (en) | 1986-08-13 |
IE860269L (en) | 1986-07-31 |
IL77742A0 (en) | 1986-07-31 |
AU5284286A (en) | 1986-08-07 |
ES8800048A1 (es) | 1987-11-01 |
DK45486A (da) | 1986-08-01 |
EG17890A (en) | 1991-03-30 |
JPH0314812B2 (zh) | 1991-02-27 |
ZA86689B (en) | 1987-09-30 |
DE3667913D1 (de) | 1990-02-08 |
US4559326A (en) | 1985-12-17 |
HU194736B (en) | 1988-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69028542T2 (de) | Felbamat zur Behandlung der Lennox-Gastaut syndrome | |
DE69930243T2 (de) | Behandlung iatrogenen und altersbedingten bluthochdruck mit vitamin b6-derivative, und pharmazeutische zusammensetzungen verwendbar dazu | |
DE69006684T2 (de) | Verwendung einer Zusammensetzung zur Herstellung eines Arzneimittels zur Behandlung der Symptome der Unenthaltsamkeit. | |
DE3590035C2 (de) | Diphenhydramin enthaltende analgetische und anti-inflammatorische Mittel und Verfahren zu ihrer Verwendung | |
DE69232016T2 (de) | Pharmazeutische zusammensetzung, die gamma-hydroxybuttersäure oder das entsprechende lakton enthält, zur behandlung von drogenabhängigkeit und ernährungsstörungen | |
DE3390114C2 (zh) | ||
DE3137125C2 (zh) | ||
DE69725879T2 (de) | VERWENDUNG VON p-AMINOPHENOLDERIVATEN ZUR HERSTELLUNG VON PHARMAZEUTISCHEN ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN | |
DE3390116C2 (de) | Verbesserte, Koffein enthaltende, analgetische und antiinflammatorische Mittel | |
DE69605531T2 (de) | Carnitinderivat als Arzneimittel zur Behandlung von Arteriosklerose obliterans | |
EP0185210A2 (de) | Verwendung von Dipeptidderivaten für die Herstellung von Arzneimitteln zur Behandlung von an amyotropher Lateralsklerose Erkrankten | |
DE69635754T9 (de) | Medikamente zur verhinderung von eingriffsbedingter stenose als folge von nicht-bypass invasiver eingriffe | |
DD242749A5 (de) | Verbesserte entzuendungshemmende zusammensetzungen und verfahren | |
EP0037488A2 (de) | Pharmazeutisches Mittel zur Heilung von entzündlichen und/oder degenerativen und/oder atrophischen Schleimhauterkrankungen | |
DE60212710T2 (de) | Pharmazeutische zubereitungen enthaltend epothilone und deren verwendung bei der behandlung von karzinoid | |
DE60204694T2 (de) | Kombinationstherapie zur behandlung von herzinsuffizienz | |
DD238920A5 (de) | Verfahren zur herstellung einer verbesserten entzuendungshemmend wirkenden zusammensetzung | |
DE69330638T2 (de) | Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem | |
EP1001756B1 (de) | Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe | |
EP0624373B1 (de) | Festes bismut- und amoxycillinhaltiges Arzneipräparat und seine Verwendung | |
DE10163667A1 (de) | Verwendung von Desoxypeganin zur Behandlung der klinischen Depression | |
DE3779991T2 (de) | Dioxopiperidin-derivate enthaltende anxiolytische zusammensetzungen. | |
DE19629802A1 (de) | Arzneimittel zur Behandlung von Neuropathien | |
DE60316775T2 (de) | Kombinationspräparat aus epothilone derivate und imidazotetrazinone | |
WO2005030332A2 (de) | Verwendung von galanthamin und seinen derivaten zum herstellen von arzneimitteln |